Commentary · 8 Oct 2025
Conference abstractPublished 2019
Atherosclerotic changes in patients with obstructive sleep apnea
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Obstructive sleep apnea syndrome (OSA) is defined as a combination of symptoms as a result of intermittent, recurrent constraint and / or complete airway overhead airway overflow (sleep disturbance). During desaturation episodes, the organism is subjected to chronic stress. This leads to reduced nitric oxide secretion, increased release of interleukin-6, tumour necrosis factor-alpha and other pro-inflammatory cytokines. The described pathological cascades are associated with the development of insulin resistance, arterial hypertension, metabolic syndrome, systemic atherosclerosis and increased cardiovascular risk. 47 patients aged 43.1±7.7 with OSA were included in this study. Their results were compared to sex and age matched healthy control. CBC, serum iron, ferritin, hsCRP, hepcidin, homocysteine and vitamin B12 were measured in the included groups. IMT and FMT were used for atherosclerotic changes evaluation. We found increased serum hepcidin levels in OSA patients with IMT and FMD changes (99.8±14.5 μg/L) compared to healthy controls (19.7±1.9 μg/L); P<0.001. IMT and FMD correlates positive in OSA patients with atherosclerotic changes to serum hepcidin concentrations (r=0.811, r=0.847, resp.; P<0.01). Serum hepcidin correlates positively to homocysteine and hsCRP in OSA patients (r=0.788, r=0.797, resp.; P<0.005).Brain-vascular disease risk factors are connected to obstructive sleep apnea syndrome. Disregulation of iron homeostasis is one of the main risk atherogenesis factors. Early hepcidin quantification might predict an atherosclerosis occurrence in OSA patients, which might be very important for better clinical diagnosis and practice.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Annals of Clinical and Laboratory Research.
Mini review · 2 Oct 2025
Characteristics and Treatment of Juvenile Myasthenia Gravis
Commentary · 9 Jul 2025
Commentary on Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: Real-World Data from 134 Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnnals of Clinical and Laboratory Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Victor Manolov”
- BylineArticles whose byline prints “Georgiev O”
- BylineArticles whose byline prints “Vasilev V”
- BylineArticles whose byline prints “Pencheva Genova V”
- BylineArticles whose byline prints “Grozdanova R”
- BylineArticles whose byline prints “Traykov L”
- BylineArticles whose byline prints “Petrova I”
- BylineArticles whose byline prints “Tzatchev K”

